These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3908619)

  • 21. Treatment results and prognostic factors of early breast cancer treated with a breast conserving operation and radiotherapy.
    Kim KJ; Huh SJ; Yang JH; Park W; Nam SJ; Kim JH; Lee JH; Kang SS; Lee JE; Kang MK; Park YJ; Nam HR
    Jpn J Clin Oncol; 2005 Mar; 35(3):126-33. PubMed ID: 15741302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined modality approach for high-risk breast cancer. The Milan Cancer Institute experience.
    Bonadonna G; Valagussa P
    Surg Oncol Clin N Am; 1995 Oct; 4(4):701-14. PubMed ID: 8535906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy.
    Pinder SE; Murray S; Ellis IO; Trihia H; Elston CW; Gelber RD; Goldhirsch A; Lindtner J; Cortés-Funes H; Simoncini E; Byrne MJ; Golouh R; Rudenstam CM; Castiglione-Gertsch M; Gusterson BA
    Cancer; 1998 Oct; 83(8):1529-39. PubMed ID: 9781946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Trials of (poly A. poly U) adjuvant immunotherapy in breast cancer treatment].
    Lacour J; Lacour F; Spira A; Delage G; Michelson AM
    Bull Cancer; 1974; 61(2):275-80. PubMed ID: 4465011
    [No Abstract]   [Full Text] [Related]  

  • 25. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant treatment of operable stomach cancer with polyadenylic.polyuridylic acid in addition to chemotherapeutic agents: a preliminary report.
    Youn JK; Kim BS; Min JS; Lee KS; Choi HJ; Lee YB; Lee DW; Park IS; Roh JK; Chung JB
    Int J Immunopharmacol; 1990; 12(3):289-95. PubMed ID: 2184135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The best available adjuvant treatments are within the framework of clinical trials. The International Breast Cancer Study Group.
    Goldhirsch A; Gelber RD; Castiglione M; Price KN; Rudenstam CM; Lindtner J; Collins J; Senn HJ; Cavalli F; Galligioni E
    Isr J Med Sci; 1995; 31(2-3):144-54. PubMed ID: 7744584
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence of lung carcinoma after surgery for breast carcinoma with and without postoperative radiotherapy. Results of National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials B-04 and B-06.
    Deutsch M; Land SR; Begovic M; Wieand HS; Wolmark N; Fisher B
    Cancer; 2003 Oct; 98(7):1362-8. PubMed ID: 14508821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Locally advanced non inflammatory breast cancer treated by combined chemotherapy and preoperative irradiation: updated results in a series of 120 patients].
    Lerouge D; Touboul E; Lefranc JP; Genestie C; Moureau-Zabotto L; Blondon J
    Cancer Radiother; 2004 Jun; 8(3):155-67. PubMed ID: 15217583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of radiotherapy in the management of operable locally advanced breast carcinoma: results of a randomized trial by the Eastern Cooperative Oncology Group.
    Olson JE; Neuberg D; Pandya KJ; Richter MP; Solin LJ; Gilchrist KW; Tormey DC; Veeder M; Falkson G
    Cancer; 1997 Mar; 79(6):1138-49. PubMed ID: 9070491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant treatment with chemotherapeutic agents and polyadenylic-polyuridylic acid in operable stomach cancers. I. Enhancement of natural killer cell activity.
    Youn JK; Kim BS; Min JS; Choi HJ; Lee YB; Lee DW; Koh EH; Kim KW; Lee KB; Michelson M
    Yonsei Med J; 1985; 26(1):1-7. PubMed ID: 4072264
    [No Abstract]   [Full Text] [Related]  

  • 32. The age-dependent efficacy of polyadenylic-polyuridylic acid therapy upon the development of spontaneous leukemia in AKR mice.
    Drake WP; Pendergrast WJ; Kramer RE; Mardiney MR
    Cancer Res; 1976 Mar; 36(3):1172-5. PubMed ID: 1253174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polyadenylic.polyuridylic acid in the cotreatment of cancer.
    Michelson AM; Lacour F; Lacour J
    Proc Soc Exp Biol Med; 1985 May; 179(1):1-8. PubMed ID: 2581264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polyadenylic-polyuridylic acid: biological response-modifying activities in mice. In vivo organ distribution and pharmacokinetics in rabbits.
    Lacour F
    J Biol Response Mod; 1985 Oct; 4(5):490-4. PubMed ID: 3878392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancement of natural killer cell activity and 2-5A synthetase in operable breast cancer patients treated with polyadenylic; polyuridylic acid.
    Hovanessian AG; Youn JK; Buffet-Janvresse C; Riviere Y; Michelson M; Lacour J; Lacour F
    Cancer; 1985 Jan; 55(2):357-62. PubMed ID: 2578083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant treatment of operable stomach cancer with polyadenylic.polyuridylic acid in addition to chemotherapeutic agents. Differential effect on natural killer cell and antibody-dependent cellular cytotoxicity.
    Youn JK; Kim BS; Min JS; Lee KS; Choi HJ; Lee YB; Lee DW; Koh EH; Kim KW; Lee KB
    Int J Immunopharmacol; 1987; 9(3):313-24. PubMed ID: 3610419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polyadenylic:polyuridylic acid-induced protection of BALB/c mice against acute murine cytomegalovirus infection.
    Adams A; Mohrman M; Johnson AG; Morin A; Deschamps de Paillette E
    J Gen Virol; 1992 Sep; 73 ( Pt 9)():2409-13. PubMed ID: 1328496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant treatment with polyadenylic-polyuridylic acid (Polya.Polyu) in operable breast cancer.
    Lacour J; Lacour F; Spira A; Michelson M; Petit JY; Delage G; Sarrazin D; Contesso G; Viguier J
    Lancet; 1980 Jul; 2(8187):161-4. PubMed ID: 6105336
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Re: perioperative acute phase response modification by polyadenylic-polyuridylic acid.
    Leris AC; Mokbel K
    Eur J Surg Oncol; 2000 Mar; 26(2):196-7. PubMed ID: 10744948
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhancement of spontaneous C3H/HeJ mammary tumorigenesis by long-term polyadenylic-polyuridylic acid therapy.
    Drake WP; Pendergrast WJ; Kramer RE; Mardiney MR
    Cancer Res; 1975 Nov; 35(11 Pt 1):3051-3. PubMed ID: 1182699
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.